Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | S-4/A | tm2227887-13_s4a.htm | S-4/A | 9886149 |
| 2 | EXHIBIT 23.1 | tm2227887d14_ex23-1.htm | EX-23.1 | 1990 |
| 3 | EXHIBIT 23.3 | tm2227887d14_ex23-3.htm | EX-23.3 | 1485 |
| 4 | EXHIBIT 99.1 | tm2227887d14_ex99-1.htm | EX-99.1 | 7767 |
| 5 | EXHIBIT 99.4 | tm2227887d14_ex99-4.htm | EX-99.4 | 2999 |
| 6 | GRAPHIC | lg_sesenbio-4c.jpg | GRAPHIC | 29732 |
| 7 | GRAPHIC | lg_carismatherapeutics-4c.jpg | GRAPHIC | 58482 |
| 8 | GRAPHIC | lg_mackenziepartners-bw.jpg | GRAPHIC | 31267 |
| 9 | GRAPHIC | tm2227887d8-tbl_pipelin4c.jpg | GRAPHIC | 162309 |
| 10 | GRAPHIC | tm2227887d8-tbl_oncolog4c.jpg | GRAPHIC | 184192 |
| 11 | GRAPHIC | tm2227887d8-fc_problem4c.jpg | GRAPHIC | 415459 |
| 12 | GRAPHIC | tm2227887d1-pht_tumor4c.jpg | GRAPHIC | 295838 |
| 13 | GRAPHIC | tm2227887d1-lc_human4c.jpg | GRAPHIC | 138754 |
| 14 | GRAPHIC | tm2227887d4-lc_contrl4c.jpg | GRAPHIC | 118658 |
| 15 | GRAPHIC | tm2227887d4-lc_reprogra4c.jpg | GRAPHIC | 317685 |
| 16 | GRAPHIC | tm2227887d1-pht_macrop4clr.jpg | GRAPHIC | 331161 |
| 17 | GRAPHIC | tm2227887d1-tbl_exvivo4c.jpg | GRAPHIC | 206128 |
| 18 | GRAPHIC | tm2227887d4-tbl_pipelin4c.jpg | GRAPHIC | 128200 |
| 19 | GRAPHIC | tm2227887d1-pht_key4c.jpg | GRAPHIC | 62915 |
| 20 | GRAPHIC | tm2227887d1-org_clinic4c.jpg | GRAPHIC | 279140 |
| 21 | GRAPHIC | tm2227887d4-bc_adverse4c.jpg | GRAPHIC | 165320 |
| 22 | GRAPHIC | tm2227887d4-lc_rapidly4c.jpg | GRAPHIC | 182292 |
| 23 | GRAPHIC | tm2227887d1-bc_single4clr.jpg | GRAPHIC | 98656 |
| 24 | GRAPHIC | tm2227887d4-bc_mostpreva4c.jpg | GRAPHIC | 165154 |
| 25 | GRAPHIC | tm2227887d4-bc_frequen4c.jpg | GRAPHIC | 123827 |
| 26 | GRAPHIC | tm2227887d14_ex99-1img001.jpg | GRAPHIC | 155355 |
| 27 | GRAPHIC | tm2227887d14_ex99-1img002.jpg | GRAPHIC | 173070 |
| 28 | GRAPHIC | tm2227887d4-tbl_selct4c.jpg | GRAPHIC | 214759 |
| 29 | GRAPHIC | tm2227887d4-lc_pt4comp4c.jpg | GRAPHIC | 161423 |
| 30 | GRAPHIC | tm2227887d1-lc_asses4c.jpg | GRAPHIC | 207283 |
| 31 | GRAPHIC | tm2227887d1-lc_itcar4c.jpg | GRAPHIC | 84717 |
| 32 | GRAPHIC | tm2227887d1-pht_profnd4clr.jpg | GRAPHIC | 747135 |
| 33 | GRAPHIC | tm2227887d1-bc_119ct4c.jpg | GRAPHIC | 171757 |
| 34 | GRAPHIC | tm2227887d4-lc_ct1119a5494c.jpg | GRAPHIC | 107894 |
| 35 | GRAPHIC | tm2227887d1-lc_carmno4c.jpg | GRAPHIC | 301180 |
| 36 | GRAPHIC | tm2227887d1-bc_cyto4c.jpg | GRAPHIC | 488368 |
| 37 | GRAPHIC | tm2227887d1-lc_polar4c.jpg | GRAPHIC | 138013 |
| 38 | GRAPHIC | tm2227887d4-lc_persis4c.jpg | GRAPHIC | 266509 |
| 39 | GRAPHIC | tm2227887d4-lc_tumor4c.jpg | GRAPHIC | 170328 |
| 40 | GRAPHIC | tm2227887d4-fc_antibody4c.jpg | GRAPHIC | 273351 |
| 41 | GRAPHIC | tm2227887d1-lc_poten4c.jpg | GRAPHIC | 137380 |
| 42 | GRAPHIC | tm2227887d1-pht_ipsc4clr.jpg | GRAPHIC | 257021 |
| 43 | GRAPHIC | tm2227887d1-bc_icar4c.jpg | GRAPHIC | 115732 |
| 44 | GRAPHIC | tm2227887d4-lc_ipscmacs4c.jpg | GRAPHIC | 199865 |
| 45 | GRAPHIC | tm2227887d1-pht_myloid4clr.jpg | GRAPHIC | 430203 |
| 46 | GRAPHIC | tm2227887d4-lc_lnp4c.jpg | GRAPHIC | 104208 |
| 47 | GRAPHIC | tm2227887d4-lc_2lnp4c.jpg | GRAPHIC | 101123 |
| 48 | GRAPHIC | tm2227887d4-lc_3lnp4c.jpg | GRAPHIC | 121886 |
| 49 | GRAPHIC | tm2227887d4-lc_4lnp4c.jpg | GRAPHIC | 101840 |
| 50 | GRAPHIC | tm2227887d4-lc_5lnp4c.jpg | GRAPHIC | 99588 |
| 51 | GRAPHIC | tm2227887d4-lc_6lnp4c.jpg | GRAPHIC | 121566 |
| 52 | GRAPHIC | tm2227887d1-pht_reprobw.jpg | GRAPHIC | 188731 |
| 53 | GRAPHIC | tm2227887d1-lc_macro4c.jpg | GRAPHIC | 205118 |
| 54 | GRAPHIC | tm2227887d4-fc_carm4c.jpg | GRAPHIC | 152276 |
| 55 | GRAPHIC | lg_svbsecurities-4c.jpg | GRAPHIC | 35073 |
| 56 | GRAPHIC | ft_svbsecurities-4c.jpg | GRAPHIC | 47561 |
| Complete submission text file | 0001104659-23-004454.txt | 22707566 |
IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-267891 | Film No.: 23532939
SIC: 2834 Pharmaceutical Preparations
